A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes ...

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

The flexibility of CRISPR/Cas9 editing is severely constrained by the requirement that the modification site is located in close proximity to the landing sequences. Here, authors develop a ...

Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline. CRISPR Therapeutics (NasdaqGM:CRSP) recently announced its Q1 2025 earnings, reporting a 71% ...

“We have demonstrated, for the first time worldwide, that CRISPR-Cas9 can be used to incorporate a desired sequence into ...

Tesla sure has a thing for random-seeming codenames for its models. The Model 3 sedan revised last year, for example, carried the internal designation "Highland." For the 3's SUV sibling ...

Furthermore, organoids were subjected to in vitro differentiation and genome editing using CRISPR/Cas9 technology ... highlighting the potential of organoids to model pathophysiology. Intestinal ...